Annabell Bachem
Dr Annabell Bachem is a research fellow in the Department of Microbiology and Immunology at The University of Melbourne. She received her PhD from the Humboldt University/Robert Koch Institute in Berlin (Germany), where she translated the key finding that CD8+ DC are superior in antigen cross-presentation from mouse to human. This resulted in the first definition of human cross-presenting DC and the ability to define these cells across different species using the now universally used marker XCR1. In 2014 she became a postdoctoral fellow of the German Research Foundation and joined the group of A/Prof Sammy Bedoui at the Peter Doherty Institute for Infection and Immunity. Supported by an Early Career Research Grant she established the study of the influence of microbiota and microbiota-derived metabolites on CD8+ T cells. In particular she demonstrated that the metabolite butyrate increases CD8+ T cell metabolism and enhances their transition to long-lived memory cells.
Abstracts this author is presenting:
